… prognostic factor, whether basic fibroblast growth factor is a favorable prognostic factor, and
whether other surrogate clinical markers, potentially released by damaged endothelial cells, …

… The inhibition of tumor growth seen with EGFR-TK inhibition is also accompanied by … growth
factor (VEGF), basic fibroblast growth factor (bFGF), and TGF-α, all potent inducers of tumor …

… -,B and is the receptor for a class of tumour growth factors (TGF-ca). The clinical correlations
… growth factor receptor may play a part in the genesis or spread of lung cancers. This is the …

… The epidermal growth factor receptor is commonly overexpressed in non-small cell lung
cancer (NSCLC; reviewed in Ref. 5) and head and neck cancers (6). In NSCLC, overexpression …

… It is well known that epidermal growth factor receptor (EGFR) … in some patients with small
cell lung cancers (SCLC). In this … The vast majority of epidermal growth factor receptor (EGFR) …

… poor prognosis in non-small-cell lung cancer (NSCLC). Tumour cell vascular endothelial
growth factor (VEGF) and platelet-derived endothelial cell growth factor (PD-ECGF) expression …

… , epidermal growth factor; EGF-R 1, a murine monoclonal epidermal growth factor receptor-…
The present study examined human lung cancer biopsy specimens for the presence of EGF …

… Growth factor research and oncogene research are closely linked based on the hypothesis
of autocrine secretion; ie, cancer cells can produce and respond to their own growth factors (1…

… non-small cell lung cancer cells, involving transactivation of the epidermal growth factor receptor
(… a central role in regulating cell proliferation and it has been therefore implicated in lung …

Despite aggressive surgical and chemotherapeutic interventions, non-small-cell lung cancer
(NSCLC) is the leading cause of cancer-related death in men and women with overall cure …